Matthew B. Klein - 28 Dec 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Issuer symbol
PTCT
Transactions as of
28 Dec 2023
Net transactions value
$0
Form type
4
Filing time
28 Dec 2023, 17:12:36 UTC
Previous filing
26 May 2023
Next filing
09 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Award $0 +75,000 +73% $0.000000 177,961 28 Dec 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit granted on December 28, 2023 that vests in four equal installments over four years, commencing on December 29, 2023.
F2 Includes 316 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023.